Share Name Share Symbol Market Type Share ISIN Share Description
Totally Plc LSE:TLY London Ordinary Share GB00BYM1JJ00 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  1.03 9.69% 11.60 5,026,167 16:35:28
Bid Price Offer Price High Price Low Price Open Price
11.50 12.00 12.35 11.25 11.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 78.01 -1.82 -2.51 21
Last Trade Time Trade Type Trade Size Trade Price Currency
17:06:25 O 500,000 12.125 GBX

Totally (TLY) Latest News (4)

More Totally News
Totally Takeover Rumours

Totally (TLY) Discussions and Chat

Totally Forums and Chat

Date Time Title Posts
28/3/202023:04Totally Health - 2014 onwards13,197
27/3/202015:58Totally plc - right of reply11
27/3/202015:28Feeling Better?550
09/3/202008:41Totally plc 20133,530
09/3/202007:20TLY with Charts & News883

Add a New Thread

Totally (TLY) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Totally trades in real-time

Totally (TLY) Top Chat Posts

Totally Daily Update: Totally Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker TLY. The last closing price for Totally was 10.58p.
Totally Plc has a 4 week average price of 9.15p and a 12 week average price of 9.15p.
The 1 year high share price is 17.13p while the 1 year low share price is currently 8.70p.
There are currently 182,186,111 shares in issue and the average daily traded volume is 415,185 shares. The market capitalisation of Totally Plc is £21,133,588.88.
1gw: Now we both know you're reading my posts nobby! The point of analysing and discussing the accounts surely is so you can make up your own mind about what they're saying. The auditor's opinion, and understanding what it's really saying, is a part of that, as are conversations with the directors. And on a decent bulletin board so are posts from different (informed) perspectives. And if we're going to throw mud related to other investments, what does your ramping of OPTI at 80p+ do for your credibility on calls here, nobby? Although I could equally pick ramping posts from you on Tly at much higher prices. --------------------------------- Nobbygnome 10 Feb '19 - 07:35 - 46260 of 57289 0 6 1 OptiBiotix - Better Science, Better Health. Better buy some! – OPTI As I have said before anyone who can look further than beyond the end of their nose, can see OPTI is a no brainer at this level. The revenue is coming and growing rapidly....and the costs are hardly changing. That is a recipe for rapid share price growth. I will repeat again this is the most elegant company I have ever seen and the best investment opportunity I have ever seen in my 30 years of investing. Nuff said.... Nobby ----------------------------------------------------------------------- Nobbygnome - 03 Feb 2018 - 10:06:50 - 2394 of 7672 Totally Health - 2014 onwards - TLY …DYOR but to me this is a no brainer at this level!...
space_bob: Sikh you need your head testing. Do you really think the (mostly) drivel posted on here affects share prices? Do you believe that if you hold shares in a company, you must support that company fanatically and not have any doubts or questions? I've simply questioned what some people have said about the supposed windfall from coronavirus. Notice that TLY themselves have not mentioned any kind of incoming windfall. Are those that are saying the share price will be almost double in a weeks time rampers, or does that not count?
pennyfalls: Mequida, I'm not so sure about the negativity over Miton and share price suppression. There's massive value here and we're in a capitalist system; others will sniff value and buy in. The share price rise has been sure and steady in a classic step-up (above 30MA) pattern, with sentiment and fundamentals following closely (after U-turning poor fundamentals) This is the time to buy without a doubt. I can't see that this would have risen much more at this time with or without Miton. It's doing ok IMO. A great Press article in one of the Sundays wouldn't go amiss. I think this was the Daily Mail's share tip for 2016 - right product, bad timing! Ps An interesting EV/ EBITDA ratio comment on the other forum. I'm not sure if poster's calculation of 4 to 5 is correct, but anything under 10 or 12 if v good (* the lower the better). Comments welcome.
spacedust: 1gw does know more than directors a d cannacord. Just look at the share price Despite buy rating of 50p the share price ended red. Despite director buy the share price ended red. So yes 1gw knows more based purely on today's share price movement. 1gw let me know when you get back.
sikhthetech: Read the company newsflow: TLY bought Vocare a couple of years ago and transformed the CQC ratings: ""Our CQC ratings have continued to improve, with further progress achieved at Vocare, which now has 19/20 registered services rated as 'Good'. Additionally, About Health, inspected for the first time, received a 'Good' rating with the 'Caring' domain rated as 'Outstanding'. We are extremely proud of these ratings which are testament to the hard work of staff across the whole Group." They are now well positioned to tender for contracts on merit. Awarding contracts on merit is a change taking place within the NHS. They bought GBH, at a decent price, in June, this year and now have a solid foundation. They had been discussing buying GBH for around a year. GBH won a NEW contract recently. They have recently, post H1 period end, announced that they intend to pay an interim dividend - progressive dividend policy, going forward would show they are confident about cash flow. "It is the intention of the Board to declare an interim dividend at the time of the interim results announcement in November 2019." Crucially, they won a NEW contract, which shows that the political situation is NOT effecting the awarding of new contracts. ALL for a mcap of £24m
sikhthetech: Bob bought 274 shares... there's a huge difference between that and the small trades, some around 10k/20k at current prices, which are by the gang manipulating the share price, so to use the TLY share price as 'evidence' not to believe my warnings on trmr... Have a look at the trmr/rthm threads on Lse and advfn... 1gw loves to mention TLY when he's caught out and to distract away from his disasters... Like on Byot today... ;-)
buywell3: TLY share price halved from Sept 1st 2016 to 15th Nov 2017 TLY share price halved again from sept 20th 2017 to 20th sept 2018 TLY share price halved again from sept 20th 2018 to 20th sept 2019 Seems like a pattern to me
grahamwales: Microscope Been here around 3 years now and all I have seen is the share price go down. All I want is for the share price to go up. That’s not too much to ask is it. Bob is playing monopoly with our money trying to build his empire and even himself admitted he doesn’t care what the share price is he will keep spending. By the way Vocare London is still failing having read some notes today. They have spent a small fortune trying to put Vocare right yet still can’t get it to work. Wendy has no idea how to run a profitable business this is not the NHS where she can spend money as and when she wants to try and improve the service Of Vocare. I try and stay positive but when I see the share price continuously drop it’s very difficult. Like I said all I want is to see the share price rise and for the BOD to stop the BS about rewarding investors and get in and do something.
nobbygnome: Well here goes. I am going to post my report although muppets like 1gw do not deserve any help with their (alleged) investment. This was probably the best company meeting I have ever been to. I was the only investor present and consequently got lots of time to ask questions and speak one to one with directors. Bob Holt was not present but all the other directors were. I am going to do this bullet point style. They were talking to Greenbrook since before the Vocare acquisition. However, it made sense to do Vocare first to get the national presence and then they could add on the London coverage of Greenbrook Wendy insisted that they did not overpay for Vocare. It maybe has taken a bit longer to sort out then they thought but it is now a profitable company. There will be cost savings during the integration due to shared functions. The enlarged group will be able to bid for more contracts than before. For example Greenbrook currently only takes on 2 new contracts a year due to logistical issues. However, now that Greenbrook have the TLY logistics they can take on more new contracts annually. There is not and never has been any cash flow issue on the balance sheet; this has been severely misrepresented by certain people. Yes there are big monthly movements in cash up and down (£3 million or so) which is why they need a big cash balance. The NHS is a very good and predictable payer which facilitates the cash flow. I spoke for a while with Michael Steel from Greenbrook. He is absolutely committed to the new business and sees the takeover as the way to rapidly grow both his business and the wider group. He is there for the long term and is very excited about the opportunities which have opened up. He has been looking to sell the business for a while to accelerate growth and patiently waited for TLY understanding the long term issues. There are multiple cross selling opportunities between the different subsidiaries. In addition, CCGs are often now approaching both Vocare and Greenbrook with contracts rather the other way round. There are very few companies which can actually bid for most of them. Probably the most interesting discussion was about the share buyback. There has been a Heads of Agreement with Greenbrook for a long time. They were waiting for a recovery in the share price to do the the purchase at a higher level, although they eventually had to bite the bullet. Don't forget they have been speaking to them since before the Vocare acquisition. This long term discussion and other issues meant that they were severely limited as to when they could actually do a buyback. In fact there were only 2 days in the whole period when the Nomad would have let them do it. You have to understand that the Vocare and Greenbrook acquisitions were a long term strategy which has been going on for years. Essentially the new enlarged group is now poised for significant growth and profitability About Health is doing very well in retaining and winning new contracts. However, the relative size means they are not always RNSed. The results will be released soon and will meet consensus from the 3 brokers. Vocare is definitely profitable! The enlarged group including the cost savings will clearly be even more profitable (my comment). Various new and existing IIs took part in the placing. Miton bought back in big (£3 million) because their earlier sale had been more of an accounting issue and the fund manager was not in agreement with the decision. Wendy thought that the vast majority of the shares were in sticky hands who would stay for the long term The money from the open offer was not required for the takeover and was just to placate PIs. So the fact that the full amount was not achieved is completely irrelevant as it just increases their cash buffer. I for one am very pleased that they enabled PIs to take part. I also spoke to the head of Vocare. He was very optimistic about the future and saw the acquisition as creating big opportunities. The geographical fit couldn't be better. The political risk is being minimised by some of the contracts being in collaboration with NHS entities. So the NHS entity wins the contract and TLY are just a partner. All the people I spoke to said the political risks were not as big as everyone think, although of course you mustn't ignore them. There is no way that the NHS could take all the urgent and managed care functions back in house. Wendy said there would be no more acquisitions in the foreseeable future. Overall I couldn't be happier about TLY now. As I have said before this is a ridiculously undervalued company. When I suggested to Wendy that the price could triple and no-one could complain, she said 'and the rest'. The company thinks that they are many fold undervalued. I think this is going to become very clear shortly as the turnover, profits and contract wins grow. I can't over emphasise how positive Michael Steel from Greenbrook was. Onwards and upwards.... Of course this is reported on a best endeavours basis and you should DYOR.
1gw: Low risk? What some of our resident rampers were arguing at a share price of around 25p in August 2018 was that Tly was low risk because of the cash on their balance sheet. I was arguing that this was illusory because of the offsetting liabilities on the balance sheet and that if they needed to fix the balance sheet by a further placing they would probably need a good discount on the share price. Fast forward 9 months to today and to me it looks like the last of the cash is likely to disappear buying Greenbrook - on the basis of them having paid around 7 x PBT or 7 x EBITDA up front for PPH and AH, and for Vocare paying up front a bit more than the cash on the Vocare balance sheet. That's assuming the FY19 Greenbrook accounts are similar to the FY18 accounts. So that leaves them having to raise cash to fix the balance sheet and pay any additional amount up front over what is on the Greenbrook balance sheet. Even if they could raise the cash at 10p (and I doubt that) that would represent a 60% loss on the 25p August share price. In what world is that consistent with tly having been a low-risk investment in August? --------------------------------------- sikhthetech - 10 Aug 2018 - 15:35:26 - 4770 of 8791 "Wouldn't you say it was just a little desperate to present Totally's cash balance relative to market cap as somehow indicative of a low risk investment?" me it's low I've explained/asked.. look at last year's placing and their prior fy2016 accounts… ----------------------------------------- Nobbygnome - 10 Aug 2018 - 11:01:42 - 4738 of 8791 …However, I agree that at this level with the level of cash TLY is very low risk.....despite what some say here. It is all about the management here IMHO...
Totally share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200329 04:54:17